HeartFlow
Founded Year
2010Stage
Debt - II | AliveTotal Raised
$757.41MLast Raised
$48.36M | 2 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-57 points in the past 30 days
About HeartFlow
HeartFlow provides a digital health service platform for heart disease diagnosis and treatments. It offers a non-invasive personalized cardiac test that provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create treatment plans for their patients. HeartFlow was formerly known as Cardiovascular Simulation. It was founded in 2010 and is based in Mountain View, California.
Loading...
HeartFlow's Product Videos
ESPs containing HeartFlow
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The cardiac CT analytics platforms market is focused on improving the diagnosis and management of heart disease through the use of artificial intelligence and advanced imaging technologies. Companies in this market use tech to accurately detect and analyze features such as coronary artery stenosis, ventricular hypertrophy, and other anomalies that can be indicative of cardiac-related diseases. Tec…
HeartFlow named as Leader among 10 other companies, including Cleerly, Ultromics, and Idoven.
HeartFlow's Products & Differentiators
HeartFlow FFRct Analysis
The HeartFlow Analysis is a personalized cardiac test that leverages algorithms trained using deep learning and highly trained analysts to create a digital, personalized 3D model of the heart. The HeartFlow Analysis then uses powerful computer algorithms to solve millions of complex equations to simulate blood flow and provides FFRCT values along the coronary arteries. This information is used by physicians in evaluating the impact a blockage may be having on blood flow and determine the optimal course of treatment for each patient.
Loading...
Research containing HeartFlow
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned HeartFlow in 3 CB Insights research briefs, most recently on Jan 5, 2024.
Aug 1, 2023
The state of healthcare AI in 5 charts
Jul 26, 2023 report
State of Digital Health Q2’23 ReportExpert Collections containing HeartFlow
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
HeartFlow is included in 5 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,270 items
Tech IPO Pipeline
568 items
Digital Health 50
150 items
The most promising digital health startups transforming the healthcare industry
Digital Health
11,306 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Artificial Intelligence
7,221 items
HeartFlow Patents
HeartFlow has filed 384 patents.
The 3 most popular patent topics include:
- cardiology
- heart diseases
- cardiac arrhythmia
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
11/6/2023 | 2/11/2025 | Medical imaging, Magnetic resonance imaging, Machine learning, Image processing, Health informatics | Grant |
Application Date | 11/6/2023 |
|---|---|
Grant Date | 2/11/2025 |
Title | |
Related Topics | Medical imaging, Magnetic resonance imaging, Machine learning, Image processing, Health informatics |
Status | Grant |
Latest HeartFlow News
Mar 27, 2025
Heartflow, Inc. , a Mountain View, CA-based leader in AI technology for coronary artery disease (CAD), received additional investments of approximately $98m through the sale and issuance of convertible notes by its parent company, Heartflow Holding, Inc. This included new investment by Fidelity Management & Research Company and additional investments from existing investors including Janus Henderson Investors, Bain Capital Life Sciences, Hayfin, US Venture Partners (USVP), HealthCor, Capricorn Investment Group and Martis Capital. Certain members of Heartflow management and the Board of Directors also participated in the financing. Proceeds from the convertible notes financing will support research and development efforts to further support Heartflow’s continued advancement of the coronary computed tomography angiography (CCTA)+Heartflow pathway as the definitive standard for the non-invasive diagnosis and management of CAD. Led by John Farquhar, president and CEO, Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. Heartflow One is a non-invasive, precision coronary care platform providing patient insights throughout the guideline-directed CCTA pathway. The AI-driven platform – including Roadmap™ Analysis, FFRCT Analysis and Plaque Analysis – is supported by the ACC/AHA Chest Pain Guideline and backed by more than 600 peer-reviewed publications. Heartflow has helped clinicians manage over 400,000 patients worldwide. FinSMEs
HeartFlow Frequently Asked Questions (FAQ)
When was HeartFlow founded?
HeartFlow was founded in 2010.
Where is HeartFlow's headquarters?
HeartFlow's headquarters is located at 331 East Evelyn Avenue, Mountain View.
What is HeartFlow's latest funding round?
HeartFlow's latest funding round is Debt - II.
How much did HeartFlow raise?
HeartFlow raised a total of $757.41M.
Who are the investors of HeartFlow?
Investors of HeartFlow include U.S. Venture Partners, HealthCor Management, Martis Capital, Scottish Mortgage Investment Trust, Capricorn Investment Group and 13 more.
Who are HeartFlow's competitors?
Competitors of HeartFlow include Cleerly and 8 more.
What products does HeartFlow offer?
HeartFlow's products include HeartFlow FFRct Analysis.
Who are HeartFlow's customers?
Customers of HeartFlow include Atrium Health.
Loading...
Compare HeartFlow to Competitors
Cleerly is a digital healthcare company focused on the diagnosis and treatment of heart disease through its solutions in the cardiovascular care sector. The company offers a digital care platform that uses non-invasive CT imaging to identify and quantify atherosclerosis, enabling treatment plans for heart disease. Cleerly's technology aims to provide phenotyping of coronary artery disease, improving the accuracy of heart attack risk assessments and supporting clinical decision-making. It was founded in 2017 and is based in Denver, Colorado.
Caristo Diagnostics specializes in cardiovascular diagnostic tools within the healthcare technology sector. The company enhances the accuracy of routine cardiac computed tomography scans by identifying coronary inflammation and other hidden cardiac issues, which improves the prediction of cardiovascular risk and aids in treatment decisions. Its technology is utilized in preventive screening, disease diagnosis, intervention planning, and clinical research. The company was founded in 2017 and is based in Oxford, United Kingdom.
Elucid specializes in advanced arterial analysis software within the healthcare technology sector. The company offers software that provides objective and quantitative assessment of arterial plaque, validated by histology, to aid in the diagnosis and treatment of cardiovascular diseases. Elucid's software is designed to support physicians, patients, and clinical researchers by improving the accuracy of non-invasive testing and enabling personalized care. It was founded in 2013 and is based in Boston, Massachusetts.
Perspectum provides imaging solutions within the healthcare industry and focuses on precision medicine. The company offers diagnostic tools that extract biomarkers from medical imaging to assist in the diagnosis and treatment of conditions, including liver disease, diabetes, and cancer. Perspectum's technology aims to help healthcare providers by offering data relevant to patient care. It was founded in 2012 and is based in Oxford, United Kingdom.
RapidFit specializes in automotive tooling manufacturing, focusing on tooling systems for the automotive industry. The company offers measurement and checking fixtures, cubing systems, jigs and calipers, and production tools, which aim to enhance manufacturing processes. RapidFit serves the automotive sector, providing tools and systems that support development cycles and manufacturing practices. It is based in Leuven, Belgium.
Anatomage specializes in advanced 3D anatomy visualization and virtual dissection technology for the education and healthcare sectors. The company's flagship product, the Anatomage Table, is a life-size virtual dissection table that offers users an interactive experience with medically accurate 3D human anatomy. Anatomage's products are designed to enhance medical education and healthcare through detailed and accurate representations of human anatomy, allowing for exploration and learning beyond traditional methods. It is based in San Jose, California.
Loading...